Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The Role of β-Catenin in Lung ILC-2 Functions

Award Number: R21AG098389
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/15/2026
PERIOD OF PERFORMANCE END DATE: 02/28/2028

Group Awards By:

View Award Description

The Role of β-Catenin in Lung ILC-2 Functions - Abstract Influenza A virus (IAV) disproportionally affects adults aged ≥ 65, resulting in significant morbidity and mortality due to impaired type-2 immune responses mediated by innate lymphoid cells group- 2 (ILC-2). Our data revealed a critical role of β-catenin in modulating ILC-2 function, which declines with age. Using innovative mouse models, we demonstrated that β-catenin stabilization enhances ILC-2 survival and function, leading to improved resistance against IAV infection. Our study utilizes both loss-of-function (LOF) and gain-of-function (GOF) mouse models to detail the effects of β-catenin levels on ILC-2 numbers and their effector functions, specifically GATA3 and T-bet expression. Results indicate that β-catenin stabilization in GOF models results in significant increases in ILC-2 counts, enhanced Th1 effector immunity, and reduced lung damage upon IAV challenge, whereas LOF models show detrimental outcomes. The proposed proposal aims to elucidate the mechanisms by which β-catenin influences ILC-2 dynamics and its interaction with key transcriptional regulators such as GATA3 and TCF-1, potentially through the canonical Wnt signaling pathway. We will examine the effects of a novel β-catenin-stabilizing small molecule, A124, on ILC-2 populations in mouse and human lung tissues. This will include examining β-catenin's role in modulating immune responses without causing systemic toxicity. Our multidisciplinary team combines expertise in ILC-2 biology, β-catenin signaling, and clinical insights from thoracic surgery and pulmonology to translate these findings into potential therapeutic strategies for enhancing immune protection in the elderly. This research is pivotal for developing targeted interventions against IAV and possibly other respiratory pathogens in vulnerable populations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $461,138 )
2026	2026	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	750 E ADAMS ST	SYRACUSE	NY	13210	ONONDAGA	USA	Aging Research	000	1	3/5/2026	NEW	$461,138
														Subtotal = $461,138

Grand Total All Awards = $461,138

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of β-Catenin in Lung ILC-2 Functions

Award Number: R21AG098389

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/15/2026

PERIOD OF PERFORMANCE END DATE: 02/28/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer